Cannasoul is a cannabis innovation, research, and technology incubator that is at the forefront of cannabis research and technology. As a drug discovery company, they are dedicated to developing groundbreaking therapeutics derived from natural compounds. Led by world-renowned cannabis researcher and pioneer Prof.

Dedi Meiri, Cannasoul bridges the gap between botanical medicine and the pharmaceutical industry. Their wide range of services includes unmatched analytics, IP licensing, clinical and pre-clinical trials, and more. Cannasoul's proprietary analytical platform and data-driven approach support active compound identification and development, from botanical extract to clinically approved formulation.

They are pioneers in mapping all active compounds of the cannabis plant and are now even developing analytical methods for psilocybin mushrooms. With a focus on discovery, formulation, and clinical studies, Cannasoul's extensive scientific capabilities and expertise in cannabis science make them a trusted source in the field. Their goal is to advance the pharmaceutical application of cannabis through rigorous clinical studies, evidence-based data, and collaborations with global leaders in the industry.

Contact Cannasoul today to discover the soul of cannabis